Vivani Medical, Inc. (VANI) — Financial statements
Income statement, balance sheet, and cash flow for Vivani Medical, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.42 | 0.00↓100.0% | 0.36 | 0.00 | 0.00 | |
| Gross Profit | -0.42 | 0.00↑100.0% | -0.36 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 18↑15.1% | 16↓7.2% | 17↑19.8% | 14↑28.8% | 11 | |
| General & Administrative Expenses | 9↑5.6% | 9↓10.7% | 10↑86.1% | 5↑131.5% | 2 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 9↑5.6% | 9↓10.7% | 10↑86.1% | 5↑131.5% | 2 | |
| Other Expenses | -0.42 | 0.00↑100.0% | -0.36↓121.0% | 2 | 0.00 | |
| Operating Expenses | 27↑9.9% | 25↓7.3% | 27↑25.3% | 21↑59.4% | 13 | |
| Total Costs & Expenses | 28↑11.7% | 25↓8.5% | 27↑26.9% | 21↑59.4% | 13 | |
| Operating Results | ||||||
| Operating Income | -28↓11.7% | -25↑8.5% | -27↓26.9% | -21↓59.4% | -13 | |
| Depreciation & Amortization | 0.42↑6.0% | 0.40↑12.0% | 0.36↓6.3% | 0.38↑10.4% | 0.35 | |
| EBITDA | -27↓11.8% | -24↑4.0% | -25↓32.0% | -19↓47.6% | -13 | |
| EBIT | -28↓11.7% | -25↑3.8% | -26↓31.3% | -20↓46.7% | -13 | |
| Interest & Other Income | ||||||
| Net Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00 | 0.00↑100.0% | -1↑22.8% | -2 | 0.00 | |
| Other Income / Expenses | 0.95↓20.5% | 1↓9.3% | 1↓82.1% | 7↑1236.7% | 0.55 | |
| Income Before Tax | -27↓13.3% | -23↑8.4% | -26↓84.7% | -14↓8.7% | -13 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -27↓13.3% | -23↑8.4% | -26↓84.7% | -14↓8.7% | -13 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -27↓13.3% | -23↑8.4% | -26↓84.7% | -14↓8.7% | -13 | |
| Bottom-Line Net Income | -27↓13.3% | -23↑8.4% | -26↓84.7% | -14↓8.7% | -13 | |
| EPS (Basic) | -0.43↑0.0% | -0.43↑14.0% | -0.50↓194.1% | -0.17↑48.5% | -0.33 | |
| EPS (Diluted) | -0.43↑0.0% | -0.43↑14.0% | -0.50↓194.1% | -0.17↑48.5% | -0.33 | |
| Weighted Average Shares | 62↑13.5% | 55↑8.1% | 51↑33.0% | 38↑5.5% | 36 | |
| Weighted Average Diluted Shares | 62↑13.5% | 55↑8.1% | 51↑33.0% | 38↑5.5% | 36 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.